Novartis Investigative Site

Fairhope, Alabama 36532

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Chronic Obstructive Pulmonary Disease

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo — Completed